PASG

3.9208.59%
MG

Maxine Gowen

Independent Chairwoman of the Board

Dr. Maxine Gowen, Ph.D., MBA, also known as Max, serves as Independent Chairwoman at Passage Bio, Inc. since November 10, 2022. She served as Interim Executive Chairwoman of Passage Bio, Inc. since June 2022 until November 10, 2022. She serves as Independent Director of Passage Bio, Inc. since February 18, 2021 and served as its Chairwomen since August 31, 2021 until June 2022. Dr. Gowen served as Board Observer at Merus N.V. since October 2020 until May 28, 2021 and served as its Independent Non-Executive Director since May 28, 2021 until 2026. Dr. Gowen is Chief Executive Officer and Director at TamuroBio Inc. Dr. Gowen serves as Director at Panorama Therapeutics, Inc. since January 1, 2020. Dr. Gowen has been an Independent Director of Aclaris Therapeutics, Inc. since July 2, 2019. Dr. Gowen Founded Trevena, Inc. in 2007 and served as its Chief Executive Officer and President from November 2007 to October 01, 2018. Dr. Gowen served as Chief Executive Officer and a Board Director of Tamuro Bio since August 2019. Dr. Gowen served as a Managing Partner at GSK Venture Fund. She served as Senior Vice President of Centre of Excellence for External Drug Discovery at GlaxoSmithKline plc since May 2005, built and led a new R&D division with a mission to create a drug discovery portfolio through business development alliances with innovative healthcare companies. She served as the President, Senior Vice President for External Drug Discovery and Managing Partner at Evergreen Fund (S.R. One Ltd.) She served as the President, Senior Vice President for External Drug Discovery and Managing Partner at SR One. She specialized in making investments in companies involved in drug discovery and pharmaceutical product development. From May 1992 to June 2002, she served in various positions at GlaxoSmithKline and its predecessor SmithKline Beecham Pharmaceuticals, including Vice President of Genetics and Discovery Ventures at GlaxoSmithKline from September 2001 to June 2002, Vice President of Musculoskeletal Diseases Drug Discovery at GlaxoSmithKline from January 2001 to 2002 and Group Director of Cellular Biochemistry at SmithKline Beecham Pharmaceuticals from May 1992 to December 2000. From November 2001 to June 2002, she served as Vice President of GSK Ventures. Dr. Gowen was Senior Lecturer and Head, Bone Cell Biology Group, Department of Bone and Joint Medicine, of the University of Bath, U.K from 1989 to 1992. She served as the Chairperson of Advisory Board and Member of Advisory Board at GlaxoSmithKline plc. She serves as a Director of Morphotek Inc. She had been a Director of Trevena, Inc. since 2008 until May 2021. Dr. Gowen has been a Director of Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) since January 4, 2016. She serves as a Director of Conforma Therapeutics Corporation. she served as the Board of Directors of Life Sciences Pennsylvania, an industry association from 2016 to 2021. She had been an Independent Director of Akebia Therapeutics, Inc. (AKBA) since July 28, 2014 until June 6, 2021. She serves as a Director of the Biotechnology Industry Association (BIO), the biotechnology industry association, from 2008 to 2018 and its affiliate, Life Sciences PA. Since July 2002, she served as a Trustee of S.R. One Limited. She served as a Director of Azelon Pharmaceuticals, Inc. since May 2005. She served as a Director of Human Genome Sciences Inc. since February 2008 until 2012. She was a Director of Nucleonics, Inc. She served as a Director of Santarus, Inc. from April 2003 to July 2004 and Predix Pharmaceuticals Holdings Inc. since August 2004. She served as a Director of Zelos Therapeutics, Inc. since May 2005. She was also named the 2010 ?Best Executive: Non-Services Business?. She is a selected as one of the Top 10 Women in Biotech by FierceBiotech. Dr. Gowen graduated with a B.Sc. in Biochemistry from the University of Bristol, UK and received a Ph.D. degree in Cell Biology from the University of Sheffield, UK. She received an MBA with academic honors from the Wharton School, University of Pennsylvania. Dr. Gowen also received a D.Sc. from the University of Bath, UK.

Positions